Cargando…
Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice
Abnormal amyloid-β (Aβ) accumulation is the most significant feature of Alzheimer’s disease (AD). Among the several secretases involved in the generation of Aβ, β-secretase (BACE1) is the first rate-limiting enzyme in Aβ production that can be utilized to prevent the development of Aβ-related pathol...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352815/ https://www.ncbi.nlm.nih.gov/pubmed/32599846 http://dx.doi.org/10.3390/ijms21124492 |
_version_ | 1783557726738055168 |
---|---|
author | Do, Jimin Kim, Namkwon Jeon, Seung Ho Gee, Min Sung Ju, Yeon-Joo Kim, Jong-Ho Oh, Myung Sook Lee, Jong Kil |
author_facet | Do, Jimin Kim, Namkwon Jeon, Seung Ho Gee, Min Sung Ju, Yeon-Joo Kim, Jong-Ho Oh, Myung Sook Lee, Jong Kil |
author_sort | Do, Jimin |
collection | PubMed |
description | Abnormal amyloid-β (Aβ) accumulation is the most significant feature of Alzheimer’s disease (AD). Among the several secretases involved in the generation of Aβ, β-secretase (BACE1) is the first rate-limiting enzyme in Aβ production that can be utilized to prevent the development of Aβ-related pathologies. Cinnamon extract, used in traditional medicine, was shown to inhibit the aggregation of tau protein and Aβ aggregation. However, the effect of trans-cinnamaldehyde (TCA), the main component of cinnamon, on Aβ deposition is unknown. Five-month-old 5XFAD mice were treated with TCA for eight weeks. Seven-month-old 5XFAD mice were evaluated for cognitive and spatial memory function. Brain samples collected at the conclusion of the treatment were assessed by immunofluorescence and biochemical analyses. Additional in vivo experiments were conducted to elucidate the mechanisms underlying the effect of TCA in the role of Aβ deposition. TCA treatment led to improvements in cognitive impairment and reduced Aβ deposition in the brains of 5XFAD mice. Interestingly, the levels of BACE1 were decreased, whereas the mRNA and protein levels of three well-known regulators of BACE1, silent information regulator 1 (SIRT1), peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC1α), and PPARγ, were increased in TCA-treated 5XFAD mice. TCA led to an improvement in AD pathology by reducing BACE1 levels through the activation of the SIRT1-PGC1α-PPARγ pathway, suggesting that TCA might be a useful therapeutic approach in AD. |
format | Online Article Text |
id | pubmed-7352815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73528152020-07-15 Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice Do, Jimin Kim, Namkwon Jeon, Seung Ho Gee, Min Sung Ju, Yeon-Joo Kim, Jong-Ho Oh, Myung Sook Lee, Jong Kil Int J Mol Sci Article Abnormal amyloid-β (Aβ) accumulation is the most significant feature of Alzheimer’s disease (AD). Among the several secretases involved in the generation of Aβ, β-secretase (BACE1) is the first rate-limiting enzyme in Aβ production that can be utilized to prevent the development of Aβ-related pathologies. Cinnamon extract, used in traditional medicine, was shown to inhibit the aggregation of tau protein and Aβ aggregation. However, the effect of trans-cinnamaldehyde (TCA), the main component of cinnamon, on Aβ deposition is unknown. Five-month-old 5XFAD mice were treated with TCA for eight weeks. Seven-month-old 5XFAD mice were evaluated for cognitive and spatial memory function. Brain samples collected at the conclusion of the treatment were assessed by immunofluorescence and biochemical analyses. Additional in vivo experiments were conducted to elucidate the mechanisms underlying the effect of TCA in the role of Aβ deposition. TCA treatment led to improvements in cognitive impairment and reduced Aβ deposition in the brains of 5XFAD mice. Interestingly, the levels of BACE1 were decreased, whereas the mRNA and protein levels of three well-known regulators of BACE1, silent information regulator 1 (SIRT1), peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC1α), and PPARγ, were increased in TCA-treated 5XFAD mice. TCA led to an improvement in AD pathology by reducing BACE1 levels through the activation of the SIRT1-PGC1α-PPARγ pathway, suggesting that TCA might be a useful therapeutic approach in AD. MDPI 2020-06-24 /pmc/articles/PMC7352815/ /pubmed/32599846 http://dx.doi.org/10.3390/ijms21124492 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Do, Jimin Kim, Namkwon Jeon, Seung Ho Gee, Min Sung Ju, Yeon-Joo Kim, Jong-Ho Oh, Myung Sook Lee, Jong Kil Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice |
title | Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice |
title_full | Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice |
title_fullStr | Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice |
title_full_unstemmed | Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice |
title_short | Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice |
title_sort | trans-cinnamaldehyde alleviates amyloid-beta pathogenesis via the sirt1-pgc1α-pparγ pathway in 5xfad transgenic mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352815/ https://www.ncbi.nlm.nih.gov/pubmed/32599846 http://dx.doi.org/10.3390/ijms21124492 |
work_keys_str_mv | AT dojimin transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice AT kimnamkwon transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice AT jeonseungho transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice AT geeminsung transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice AT juyeonjoo transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice AT kimjongho transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice AT ohmyungsook transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice AT leejongkil transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice |